Data as of Aug 20
| +0.90 / +1.93%|
The 42 analysts offering 12-month price forecasts for Dr.Reddy's Laboratories Ltd have a median target of 52.10, with a high estimate of 65.57 and a low estimate of 41.50. The median estimate represents a +9.60% increase from the last price of 47.54.
The current consensus among 43 polled investment analysts is to Buy stock in Dr.Reddy's Laboratories Ltd. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.